ClinicalTrials.gov
ClinicalTrials.gov Menu

Coronary Artery Study in Pediatric Heart Transplantation (CAS-POHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01546870
Recruitment Status : Withdrawn (never approved by IRB)
First Posted : March 7, 2012
Last Update Posted : June 20, 2016
Sponsor:
Collaborator:
University of Arkansas
Information provided by (Responsible Party):
Arkansas Children's Hospital Research Institute

Brief Summary:
Transplant coronary artery disease (TCAD) is a significant cause of morbidity and mortality in pediatric heart transplantation (PHT). Understanding the pathophysiology and early detection along with attempted medical management are crucial in preventing advancement of the disease and retransplantation or mortality. Coronary angiogram, although routinely used is insensitive to detect early TCAD. Measurement of fractional flow reserve (FFR), coronary flow reserve (CFR) and index of microvascular resistance (IMR) using a doppler pressure and flow intracoronary wire may be more sensitive in evaluating the integrity of coronary vasculature and thus detect pre clinical TCAD. To the best of the investigators knowledge, measurement of these parameters has not been previously reported in PHT.

Condition or disease
Transplant Coronary Artery Disease

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Case-Only
Time Perspective: Prospective
Study Start Date : April 2012
Actual Primary Completion Date : April 2012
Actual Study Completion Date : April 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
pediatric heart transplant recipients



Primary Outcome Measures :
  1. Clinical coronary artery disease [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   7 Years to 21 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pediatric heart transplant recipients
Criteria

Inclusion Criteria:

  • less than 21 years and above 7 years of age

Exclusion Criteria:

  • clinically significant coronary artery disease on angiography and inability to undergo IVUS

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01546870


Locations
United States, Arkansas
Arkansas Children's hospital
Little Rock, Arkansas, United States, 72223
Sponsors and Collaborators
Arkansas Children's Hospital Research Institute
University of Arkansas

Publications:
Responsible Party: Arkansas Children's Hospital Research Institute
ClinicalTrials.gov Identifier: NCT01546870     History of Changes
Other Study ID Numbers: ArkansasChRI
First Posted: March 7, 2012    Key Record Dates
Last Update Posted: June 20, 2016
Last Verified: June 2016

Additional relevant MeSH terms:
Coronary Artery Disease
Myocardial Ischemia
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases
Vascular Diseases